FDA, COVID-19 and Moderna
Digest more
The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at higher risk of severe disease, but will require vaccine makers to conduct major new clinical trials before approving them for wider use.
The US Food and Drug Administration will now require Covid-19 vaccines from Pfizer/BioNTech and Moderna to use expanded warning labels with more information about the risk of a rare heart condition after vaccination.
Previously, updated COVID vaccines had been recommended annually by the CDC for everyone over the age of 6 months. The CDC has historically set vaccine recommendations, while the FDA determines which vaccines to authorize or approve after being deemed safe and effective.
The Centers for Disease Control and Prevention says children without underlying health conditions "may receive" a COVID-19 vaccine, contradicting a directive by Health and Human Services Secretary Robert F.
1d
Health on MSNWhy Experts Are Pushing Back on New COVID Shot Guidance for Healthy Kids, Pregnant PeopleThe HHS has removed the COVID shot from the CDC's recommended list of vaccines for these groups. Experts say they're still at risk, and the decision could limit access to the shot.
A new, highly transmissible COVID subvariant has been detected in California — heightening the risk of a summer wave as recent moves by the Trump administration threaten to make vaccines harder to get,
A new Covid variant that’s gaining momentum globally has landed in the U.S. The World Health Organization announced last week that it was monitoring the variant, NB.1.8.1, following a rise in cases in several parts of the world, including Europe, Southeast Asia and North and South America.
The US Department of Health and Human Services, under Secretary Robert F. Kennedy Jr., has recently made significant changes to how Covid-19 vaccines are approved and the groups they are recommended for.